Compounds > razoxane

Page last updated: 2024-08-23

razoxane and Malignant Melanoma

razoxane has been researched along with Malignant Melanoma in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (87.50)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (12.50)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boehler, F; Eiter, H; Rhomberg, W; Saely, C; Strohal, R	1
Finch, M; Hellmann, K; Hutchinson, GE; Li, XT; Pym, BA	1
Campbell, ED; Carter, WH; Stablein, DM; Wampler, GL	1
Campolito, LB; George, T; Reiches, NA; Witiak, DT; Zwilling, BS	1
Bellet, RE; Muggia, FM; Penta, JS; Rozencweig, M; Von Hoff, DD; Wasserman, TH	1
Ahmann, DL; Bisel, HF; Edmonson, JH; Frytak, S; Kvols, LK; Rubin, J	1
Ingber, DE; Lazo, JS; Sartorelli, AC	1
Elliott, P; Madden, FJ; Mould, RF; Newlands, ES; Newton, KA; Oon, CJ; Roberts, JT; Topham, C; Westbury, G	1

Trials

1 trial(s) available for razoxane and Malignant Melanoma

Article	Year
Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma. British journal of cancer, 1976, Volume: 34, Issue:2 Topics: Antigens, Neoplasm; BCG Vaccine; Dacarbazine; Drug Therapy, Combination; Female; Humans; Immunotherapy; Male; Melanoma; Piperazines; Prognosis; Razoxane; Triazenes	1976

Other Studies

7 other study(ies) available for razoxane and Malignant Melanoma

Article	Year
Combined razoxane and radiotherapy for melanoma brain metastases. a retrospective analysis. Journal of neuro-oncology, 2005, Volume: 74, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Male; Melanoma; Middle Aged; Radiotherapy; Razoxane; Retrospective Studies; Treatment Outcome	2005
Effect of AT1727 on growth and metastasis of murine tumours. European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:2 Topics: Animals; Antineoplastic Agents; Drug Administration Schedule; Female; Leukemia L1210; Lung Neoplasms; Lymphoma; Male; Melanoma; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Piperazines; Razoxane; Sarcoma 180	1983
Drug activity and therapeutic synergism in cancer treatment. Cancer research, 1982, Volume: 42, Issue:8 Topics: Animals; Antineoplastic Agents; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Melanoma; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Experimental; Rats; Razoxane; Teniposide	1982
Effect of stereoisomers related to ICRF-159 on metastasis of B16 melanoma. British journal of cancer, 1981, Volume: 44, Issue:4 Topics: Animals; Cell Division; Cell Line; Cell Survival; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Piperazines; Razoxane; Stereoisomerism	1981
ICRF-159: current status and clinical prospects. European journal of cancer, 1977, Volume: 13, Issue:11 Topics: Alopecia; Animals; Colonic Neoplasms; Humans; Leukopenia; Lung Neoplasms; Lymphoma; Melanoma; Mice; Nausea; Neoplasms, Experimental; Piperazines; Razoxane; Rectal Neoplasms; Sarcoma	1977
Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma. Cancer treatment reports, 1978, Volume: 62, Issue:1 Topics: Cisplatin; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Kidney; Male; Melanoma; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous; Triazenes	1978
Enhancement of experimental lung metastases by cultured B16 melanoma cells treated with (+/-)-1,2-bis(3,5-dioxopiperazin-1-y)propane (ICRF-159). Cancer research, 1978, Volume: 38, Issue:8 Topics: Animals; Cell Division; Cell Survival; Female; Glycosaminoglycans; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Piperazines; Razoxane; Transplantation, Isogeneic	1978